Genscript Biotech Market Cap

Genscript Biotech has a market cap or net worth of $3.13 billion as of April 24, 2025. Its market cap has decreased by -18.78% in one year.

Market Cap

3.13B

Enterprise Value

3.24B

Revenue

594.49M

Ranking

n/a

PE Ratio

1.06

Stock Price

$1.30

Market Cap Chart

Since December 30, 2015, Genscript Biotech's market cap has increased from 272.50M to 3.13B, an increase of 1,048.86%. That is a compound annual growth rate of 29.93%.

Market Cap History

Date	Market Cap	% Change
Apr 24, 2025	3.12B	15.06%
Dec 31, 2024	2.72B	-49.68%
Dec 29, 2023	5.40B	-19.93%
Dec 30, 2022	6.74B	-27.50%
Dec 31, 2021	9.30B	227.16%
Dec 31, 2020	2.84B	-33.34%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
SS Innovations International	1.74B
Endo Inc.	1.64B
Nika Pharmaceuticals	1.02B
Veradigm	704.15M
Elite Pharmaceuticals	436.82M
Northwest Biotherapeutics	402.62M
Glass House Brands	384.26M
CytoDyn	264.36M

Market Cap Rankings